Mesenchymal transition in kidney collecting duct epithelial cells.
暂无分享,去创建一个
[1] W. Nelson,et al. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. , 2008, Biochimica et biophysica acta.
[2] C. Pin,et al. The role of the type I insulin-like growth factor receptor (IGF-IR) in glomerular integrity. , 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[3] A. Tarantal,et al. Collecting duct epithelial-mesenchymal transition in fetal urinary tract obstruction. , 2007, Kidney international.
[4] B. Willis,et al. TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease , 2007 .
[5] A. Mercurio,et al. Epithelial-Mesenchymal Transition and Colorectal Cancer: Gaining Insights into Tumor Progression Using LIM 1863 Cells , 2007, Cells Tissues Organs.
[6] E. Bottinger. TGF-β in renal injury and disease , 2007 .
[7] Adrian V. Lee,et al. Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail , 2007, Molecular and Cellular Biology.
[8] J. Jimenez-Heffernan,et al. Epithelial-to-mesenchymal transition of the mesothelial cell--its role in the response of the peritoneum to dialysis. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] E. Simpson,et al. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[10] A. E. El Nahas,et al. An IGF-I antagonist does not inhibit renal fibrosis in the rat following subtotal nephrectomy. , 2006, American journal of physiology. Renal physiology.
[11] M. Jinnin,et al. Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-β1-Induced Extracellular Matrix Expression , 2006, Molecular Pharmacology.
[12] N. Wahab,et al. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. , 2006, The Biochemical journal.
[13] Youhua Liu,et al. Renal fibrosis: new insights into the pathogenesis and therapeutics. , 2006, Kidney international.
[14] S. Merajver,et al. Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells , 2005, Breast Cancer Research.
[15] G. Adler,et al. TGFβ-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN , 2005, Journal of Cell Science.
[16] A. Melk,et al. Epithelial to Mesenchymal Transition During Late Deterioration of Human Kidney Transplants: The Role of Tubular Cells in Fibrogenesis , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] D. Matsell,et al. Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway. , 2005, Kidney international.
[18] F. Moreso,et al. Evaluation of pre-implantation kidney biopsies: comparison of Banff criteria to a morphometric approach. , 2005, Kidney international.
[19] K. Schlessinger,et al. GSK-3β sets Snail's pace , 2004, Nature Cell Biology.
[20] A. Nakao,et al. Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction. , 2004, Kidney international.
[21] A. Negri. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents. , 2004, Journal of nephrology.
[22] H. Werner,et al. IGF, IGF receptor and overgrowth syndromes. , 2004, Pediatric endocrinology reviews : PER.
[23] K. Flanders,et al. Smad3 as a mediator of the fibrotic response , 2004, International journal of experimental pathology.
[24] K. B. F. Rocha,et al. The Role of Myofibroblasts and Interstitial Fibrosis in the Progression of Membranous Nephropathy , 2004, Renal failure.
[25] R. Kalluri,et al. Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.
[26] A. Roberts,et al. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. , 2003, The Journal of clinical investigation.
[27] A. Ivanov,et al. Endocytosis of epithelial apical junctional proteins by a clathrin-mediated pathway into a unique storage compartment. , 2003, Molecular biology of the cell.
[28] A. Klippel,et al. Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4 , 2003, Oncogene.
[29] R. Montesano,et al. Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells. , 2003, American journal of physiology. Cell physiology.
[30] D. Matsell,et al. Increased expression of insulin-like growth factors in progressive glomerulonephritis of the MRL lpr mouse , 2003, Lupus.
[31] R. Kalluri,et al. BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury , 2003, Nature Medicine.
[32] Xi He,et al. A Wnt-Wnt situation. , 2003, Developmental cell.
[33] E. Neilson,et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.
[34] J. Stow,et al. Protein kinase C regulates endocytosis and recycling of E-cadherin. , 2002, American journal of physiology. Cell physiology.
[35] M. Rastaldi,et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. , 2002, Kidney international.
[36] R. Atkins,et al. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] Junwei Yang,et al. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. , 2001, The American journal of pathology.
[38] Véronique Delmas,et al. IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition , 2001, Oncogene.
[39] R. Kucherlapati,et al. Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient Fibroblasts* , 2001, The Journal of Biological Chemistry.
[40] J. Chapman,et al. EFFECT OF HISTOLOGICAL DAMAGE ON LONG-TERM KIDNEY TRANSPLANT OUTCOME , 2001, Transplantation.
[41] V. Han,et al. Fetal rhesus monkey model of obstructive renal dysplasia. , 2001, Kidney international.
[42] D. Leroith,et al. Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1. , 2000, Kidney international.
[43] A. G. de Herreros,et al. Regulation of E-cadherin/Catenin Association by Tyrosine Phosphorylation* , 1999, The Journal of Biological Chemistry.
[44] T. Matozaki,et al. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells – regulation by Rho, Rac and Rab small G proteins , 1999, Oncogene.
[45] D. Matsell. Renal dysplasia: new approaches to an old problem. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[46] R. Atkins,et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. , 1998, Kidney international.
[47] A. Ridley,et al. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. , 1998, Molecular biology of the cell.
[48] V. Han,et al. The pathogenesis of multicystic dysplastic kidney disease: insights from the study of fetal kidneys. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[49] A. Eddy. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. , 1994, Journal of the American Society of Nephrology : JASN.
[50] V. Han,et al. Expression of insulin-like growth factor and binding protein genes during nephrogenesis. , 1994, Kidney international.
[51] S. Gullans,et al. An osmotically tolerant inner medullary collecting duct cell line from an SV40 transgenic mouse. , 1993, The American journal of physiology.
[52] S. Klahr,et al. Transforming growth factor-beta induces renal epithelial jagged-1 expression in fibrotic disease. , 2002, Journal of the American Society of Nephrology : JASN.
[53] G. Striker,et al. Autocrine activation of the IGF-I signaling pathway in mesangial cells isolated from diabetic NOD mice. , 2002, Diabetes.
[54] E. Dejana,et al. Regulation of cadherin function by Rho and Rac: modulation by junction maturation and cellular context. , 1999, Molecular biology of the cell.
[55] V. Han,et al. Insulin-like growth factor (IGF) and IGF binding protein gene expression in multicystic renal dysplasia. , 1997, Journal of the American Society of Nephrology : JASN.
[56] C. Brown,et al. Myofibroblasts and the progression of diabetic nephropathy. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[57] G. Striker,et al. Glomerulosclerosis: studies of its pathogenesis in humans and animals. , 1994, Contributions to nephrology.
[58] R. Roeder,et al. Eukaryotic gene transcription with purified components. , 1983, Methods in enzymology.